Stockreport
This CEO has battled billionaire activist Carl Icahn twice — here's his advice to Disney CEO Bob Iger [Yahoo! Finance]
Last hologic, inc. earnings: 4/29 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations: investors.hologic.com
That's just some friendly advice to Bob Iger, from veteran Hologic ( HOLX ) CEO and Illumina ( ILMN ) chairman Stephen MacMillan. "You have got to get serious about succession. To me, that's where the Disney board has failed," MacMillan told me in an exclusive interview for Yahoo Finance. MacMillan — who has been the CEO of medical device maker Hologic since December 2013 — knows a thing or twelve about mixing it up with high-profile activists. Billionaire activist investor Carl Icahn came knocking on the door of Hologic in November 2013, taking a 12.63% stake and demanding board representation. He also wanted to discuss ways to unlock shareholder value at the then-bumbling company. Hologic proceeded to enact a poison pill, a common move in a potential hostile takeover situation. By December 2013, the company added two Icahn representatives to its board and booted its CEO in favor of MacMillan, the former CEO of medical device developer Stryker ( SYK MacMillan moved quick
[Read more]
| IMPACT SNAPSHOT | EVENT TIME: | HOLX | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| LAST PRICE | ||
| VWAP | ||
|
High:
|
MAX UP |
High:
|
|
Low:
|
MAX DOWN |
Low:
|
|
%
|
POST NEWS RANGE |
%
|
|
|
PRICE CHANGE |
|
|
|
PRICE CHANGE PERCENTAGE |
|
|
|
S&P 500 (SPX) |
|
|
%
|
VOLUME RATIO |
%
|
| VOLUME (SHARES) | ||
| TICKS | ||
|
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
HOLX alerts
HOLX alerts
from News Quantified
Movers & Shakers
The biggest gainers and losers and WHY it moved
HOLX alerts
High impacting Hologic, Inc. news events
Weekly update
A roundup of the hottest topics
HOLX
NEWS
NEWS
- Hologic (HOLX) Is Considered a Good Investment by Brokers: Is That True? [Yahoo! Finance][Yahoo! Finance]
- Hologic: Women's Health Play Looks Healthier Itself May 13, 2024 3:56 AM ET [Seeking Alpha][Seeking Alpha]
- Hologic, Inc. (NASDAQ: HOLX) had its price target raised by analysts at Argus from $89.00 to $95.00. They now have a "buy" rating on the stock.[MarketBeat]
- $2.75+ Epigenetic Markets - Global Industry Size, Share, Trends, Opportunity, and Forecasts, 2019-2023 & 2024-2029F [Yahoo! Finance][Yahoo! Finance]
- A Dive into Hologic (HOLX) International Revenue Trends and Forecasts [Yahoo! Finance][Yahoo! Finance]
- More
HOLX
SEC Filings
SEC Filings
- 5/3/24 - Form 8-K/A
- 5/3/24 - Form 10-Q
- 5/2/24 - Form 8-K
- HOLX's page on the SEC website
- More